PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma

[EN]Background: Precision medicine is a promising strategy to identify biomarkers, stratify asthmatic patients according to different endotypes, and match them with the appropriate therapy. This proof-of-concept study aimed to investigate whether gene expression in peripheral blood could provide a v...

Descripción completa

Detalles Bibliográficos
Autores: García Sánchez, María Asunción, Estravís Sastre, Miguel, Martin, Maria J., Pérez-Pazos, Jacqueline, Martín-García, Cristina, Gil Melcón, María, Ramos González, Jacinto, Eguiluz-Gracia, Ibon, Triviño, Juan Carlos, Isidoro García, María, Dávila González, Ignacio Jesús, Sanz Lozano, Catalina Sofía
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/158644
Acceso en línea:http://hdl.handle.net/10366/158644
Access Level:acceso abierto
Palabra clave:PTGDR2
Aspirin exacerbated respiratory disease (AERD)
Asthma
Biomarker
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Gene expression
Allergy and Immunology
Genetics
3207.01 Alergias
2409 Genética
alergia e inmunología
id ES_780eef44e6483df2921e7cdaf376fcaa
oai_identifier_str oai:gredos.usal.es:10366/158644
network_acronym_str ES
network_name_str España
repository_id_str
spelling PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthmaGarcía Sánchez, María AsunciónEstravís Sastre, MiguelMartin, Maria J.Pérez-Pazos, JacquelineMartín-García, CristinaGil Melcón, MaríaRamos González, JacintoEguiluz-Gracia, IbonTriviño, Juan CarlosIsidoro García, MaríaDávila González, Ignacio JesúsSanz Lozano, Catalina SofíaPTGDR2Aspirin exacerbated respiratory disease (AERD)AsthmaBiomarkerChronic rhinosinusitis with nasal polyps (CRSwNP)Gene expressionAllergy and ImmunologyGenetics3207.01 Alergias2409 Genéticaalergia e inmunología[EN]Background: Precision medicine is a promising strategy to identify biomarkers, stratify asthmatic patients according to different endotypes, and match them with the appropriate therapy. This proof-of-concept study aimed to investigate whether gene expression in peripheral blood could provide a valuable noninvasive approach for the molecular phenotyping of asthma. Methods: We performed whole-transcriptome RNA sequencing on peripheral blood of 30 non-atopic non-asthmatic controls and 30 asthmatic patients. A quantitative PCR (qPCR) validation study of PTGDR2 that encodes for CRTH2 receptor, expressed in cells involved in T2 inflammation, was developed in a cohort of 361 independent subjects: 94 non-asthmatic non-atopic controls, 187 asthmatic patients [including 82 with chronic rhinosinusitis with nasal polyposis (CRSwNP) and 24 with aspirin-exacerbated respiratory disease (AERD)], 52 with allergic rhinitis, and 28 with CRSwNP without asthma. Results: PTGDR2 was one of the most differentially overexpressed genes in asthmatic patients' peripheral blood (p-value 2.64 × 106). These results were confirmed by qPCR in the validation study, where PTGDR2 transcripts were significantly upregulated in asthmatic patients (p < 0.001). This upregulation was mainly detected in some subgroups such as allergic asthma, asthma with CRSwNP, AERD, eosinophilic asthma, and severe persistent asthma. PTGDR2 expression was detected in different blood cell types, and its correlation with eosinophil counts showed differences in some groups of asthmatic patients. Conclusions: We found that PTGDR2 expression levels could identify asthma patients, introduce a minimally invasive biomarker for adult asthma molecular phenotyping, and add additional information to blood eosinophils. Although further studies are required, analyzing PTGDR2 expression levels in peripheral blood of asthmatics might assist in selecting patients for treatment with specific antagonists. Keywords: PTGDR2; aspirin exacerbated respiratory disease (AERD); asthma; biomarker; chronic rhinosinusitis with nasal polyps (CRSwNP); gene expression.Instituto de Salud Carlos III; Juan Rodés contract; Junta de Castilla y LeónMDPI202420242021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10366/158644reponame:GREDOS. Repositorio Institucional de la Universidad de Salamancainstname:Universidad de Salamanca (USAL)InglésAttribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:gredos.usal.es:10366/1586442026-06-07T06:28:51Z
dc.title.none.fl_str_mv PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
title PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
spellingShingle PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
García Sánchez, María Asunción
PTGDR2
Aspirin exacerbated respiratory disease (AERD)
Asthma
Biomarker
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Gene expression
Allergy and Immunology
Genetics
3207.01 Alergias
2409 Genética
alergia e inmunología
title_short PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
title_full PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
title_fullStr PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
title_full_unstemmed PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
title_sort PTGDR2 expression in peripheral blood as a potential biomarker in adult patients with asthma
dc.creator.none.fl_str_mv García Sánchez, María Asunción
Estravís Sastre, Miguel
Martin, Maria J.
Pérez-Pazos, Jacqueline
Martín-García, Cristina
Gil Melcón, María
Ramos González, Jacinto
Eguiluz-Gracia, Ibon
Triviño, Juan Carlos
Isidoro García, María
Dávila González, Ignacio Jesús
Sanz Lozano, Catalina Sofía
author García Sánchez, María Asunción
author_facet García Sánchez, María Asunción
Estravís Sastre, Miguel
Martin, Maria J.
Pérez-Pazos, Jacqueline
Martín-García, Cristina
Gil Melcón, María
Ramos González, Jacinto
Eguiluz-Gracia, Ibon
Triviño, Juan Carlos
Isidoro García, María
Dávila González, Ignacio Jesús
Sanz Lozano, Catalina Sofía
author_role author
author2 Estravís Sastre, Miguel
Martin, Maria J.
Pérez-Pazos, Jacqueline
Martín-García, Cristina
Gil Melcón, María
Ramos González, Jacinto
Eguiluz-Gracia, Ibon
Triviño, Juan Carlos
Isidoro García, María
Dávila González, Ignacio Jesús
Sanz Lozano, Catalina Sofía
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv PTGDR2
Aspirin exacerbated respiratory disease (AERD)
Asthma
Biomarker
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Gene expression
Allergy and Immunology
Genetics
3207.01 Alergias
2409 Genética
alergia e inmunología
topic PTGDR2
Aspirin exacerbated respiratory disease (AERD)
Asthma
Biomarker
Chronic rhinosinusitis with nasal polyps (CRSwNP)
Gene expression
Allergy and Immunology
Genetics
3207.01 Alergias
2409 Genética
alergia e inmunología
description [EN]Background: Precision medicine is a promising strategy to identify biomarkers, stratify asthmatic patients according to different endotypes, and match them with the appropriate therapy. This proof-of-concept study aimed to investigate whether gene expression in peripheral blood could provide a valuable noninvasive approach for the molecular phenotyping of asthma. Methods: We performed whole-transcriptome RNA sequencing on peripheral blood of 30 non-atopic non-asthmatic controls and 30 asthmatic patients. A quantitative PCR (qPCR) validation study of PTGDR2 that encodes for CRTH2 receptor, expressed in cells involved in T2 inflammation, was developed in a cohort of 361 independent subjects: 94 non-asthmatic non-atopic controls, 187 asthmatic patients [including 82 with chronic rhinosinusitis with nasal polyposis (CRSwNP) and 24 with aspirin-exacerbated respiratory disease (AERD)], 52 with allergic rhinitis, and 28 with CRSwNP without asthma. Results: PTGDR2 was one of the most differentially overexpressed genes in asthmatic patients' peripheral blood (p-value 2.64 × 106). These results were confirmed by qPCR in the validation study, where PTGDR2 transcripts were significantly upregulated in asthmatic patients (p < 0.001). This upregulation was mainly detected in some subgroups such as allergic asthma, asthma with CRSwNP, AERD, eosinophilic asthma, and severe persistent asthma. PTGDR2 expression was detected in different blood cell types, and its correlation with eosinophil counts showed differences in some groups of asthmatic patients. Conclusions: We found that PTGDR2 expression levels could identify asthma patients, introduce a minimally invasive biomarker for adult asthma molecular phenotyping, and add additional information to blood eosinophils. Although further studies are required, analyzing PTGDR2 expression levels in peripheral blood of asthmatics might assist in selecting patients for treatment with specific antagonists. Keywords: PTGDR2; aspirin exacerbated respiratory disease (AERD); asthma; biomarker; chronic rhinosinusitis with nasal polyps (CRSwNP); gene expression.
publishDate 2021
dc.date.none.fl_str_mv 2021
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10366/158644
url http://hdl.handle.net/10366/158644
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname:Universidad de Salamanca (USAL)
instname_str Universidad de Salamanca (USAL)
reponame_str GREDOS. Repositorio Institucional de la Universidad de Salamanca
collection GREDOS. Repositorio Institucional de la Universidad de Salamanca
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869411180485804032
score 15.81155